Case Report
Accepted on 18 Feb 2026
Upadacitinib in refractory ulcerative colitis patients with high thromboembolic risk: two case reports
in Autoimmune and Autoinflammatory Disorders: Autoinflammatory Disorders
Case Report
Accepted on 18 Feb 2026
in Autoimmune and Autoinflammatory Disorders: Autoinflammatory Disorders
Original Research
Accepted on 18 Feb 2026
in Reproduction
Original Research
Accepted on 18 Feb 2026
in Geohazards and Georisks
Original Research
Accepted on 18 Feb 2026
in Gastrointestinal Cancers: Gastric and Esophageal Cancers
Methods
Accepted on 18 Feb 2026
in Statistics and Probability
Original Research
Accepted on 18 Feb 2026
in Molecular Diagnostics and Therapeutics
Case Report
Accepted on 18 Feb 2026
in Dermatology
Original Research
Accepted on 18 Feb 2026
in Public Health Education and Promotion
Review
Accepted on 18 Feb 2026
in Environmental Psychology
Opinion
Accepted on 18 Feb 2026
in Public Health Education and Promotion
Original Research
Accepted on 18 Feb 2026
in Public Health Education and Promotion
Original Research
Accepted on 18 Feb 2026
in Personality and Social Psychology
Original Research
Accepted on 18 Feb 2026
in Inflammation
Original Research
Accepted on 18 Feb 2026
in Inflammation
Original Research
Accepted on 18 Feb 2026
in Addictive Disorders
Perspective
Accepted on 18 Feb 2026
in Disaster Communications